Check our latest news and where we are going to be soon.

2211, 2021

Immunobiogram® has been granted a US patent by USPTO

Biohope´s lead product, the Immunobiogram®, has been granted a US patent by the United States Patent and Trademark Office. This new patent complements and consolidates  Biohope´s  intellectual property protection facilitating the commercial expansion in a key market

802, 2021

Recent Publication by Biohope in Frontiers in Immunology.

The prestigious international journal, “Frontiers in Immunology”, has recently published a paper about the Immunobiogram technology, called “The Immunobiogram, a Novel In Vitro Assay to Evaluate Treatment Resistance in Patients Receiving Immunosuppressive Therapy” . Frontiers in Immunology is a leading journal in its field,

2210, 2020

Biohope reached the CE Mark for the IMMUNOBIOGRAM®

In October, Biohope reached the CE Mark for the IMMUNOBIOGRAM®, a first in class IVD test for the in-vitro measurement of metabolic activity of patient’s immune cells as response to individual immunosuppressive drugs. Therefore, for patients